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Insight into how the mammalian genome is structured in vivo is key to understanding transcriptional regu-
lation. This is especially true in complex domains in which genes are coordinately regulated by long-range
interactions between cis-regulatory elements. The regulation of the H19/Igf2 imprinted region depends on
the presence of several cis-acting sequences, including a methylation-sensitive insulator between Igf2 and
H19 and shared enhancers downstream of H19. Each parental allele has a distinct expression pattern.
We used chromosome conformation capture to assay the native three-dimensional organization of the
H19/Igf2 locus on each parental copy. Furthermore, we compared wild-type chromosomes to several
mutations that affect the insulator. Our results show that promoters and enhancers reproducibly co-localize
at transcriptionally active genes, i.e. the endodermal enhancers contact the maternal H19 and the paternal
Igf2 genes. The active insulator blocks trafﬁc of the enhancers along the chromosome, restricting them to
the H19 promoter. Conversely, the methylated inactive insulator allows the enhancers to contact the
upstream regions, including Igf2. Mutations that either remove or inhibit insulator activity allow unrestricted
access of the enhancers to the whole region. A mutation that allows establishment of an enhancer-blocker on
the normally inactive paternal copy diminishes the contact of the enhancer with the Igf2 gene. Based on our
results, we propose that physical proximity of cis-acting DNA elements is vital for their activity in vivo.W e
suggest that enhancers track along the chromosome until they ﬁnd a suitable promoter sequence to interact




expression are achieved. Within a certain domain, expression
patterns are determined by the interaction of several regulatory
elements, including promoters, enhancers and insulators. Epi-
genetic modiﬁcations, such as DNA methylation, can modify
the interactions between genes and their regulatory sequences.
Inthecaseofimprintedgenes,twoalleleswithparental-speciﬁc
epigenetic modiﬁcations coexist and result in distinct allelic
expression patterns.
At the H19/Igf2 locus, common enhancers activate H19 on
the maternal chromosome and Igf2 on the paternal chromo-
some (1–4). The allele-speciﬁc pattern is due to the epigenetic
switch of an insulator/transcriptional activator lying upstream
of H19 (5), designated as the differentially methylated domain
(DMD). On the maternal chromosome, this region binds to
CTCF (6–10), with two outcomes: H19 expression is initiated
in the blastocyst (11,12) and the enhancers driving this tran-
scription are blocked from activating Igf2 promoters on that
chromosome. On the paternal chromosome, the region is
hypermethylated (11,13), CTCF does not bind and the enhan-
cers can access the Igf2 promoters to drive transcription pater-
nally. Subsequent methylation of the H19 promoter inhibits its
expression.
We have developed several mouse models to investigate the
requirement of the DMD for proper imprinting regulation and
to determine the role of CTCF binding to the DMD by generat-
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H19
D3.8–50H19 line has3.8 kb upstream ofthe H19 geneencom-
passing the DMD deleted (14), resulting in biallelic Igf2
expression when the allele is inherited maternally. In the
H19
DMD-DR mutation, only the CTCF binding sites within the
DMD have been deleted (12). We have shown that in this line,
the maternal insulator cannot be established, and that transcrip-
tionalinitiationofH19isdelayed.IntheH19
9CG-DMDline,9CG
dinucleotides within the CTCF binding sites have been muta-
genized (10), and although methylation is established when
inheritedpaternally,CTCFisabletobindtotheDMDandestab-
lish an ectopic enhancer-blocker, resulting in decreased levels
of Igf2.
These experiments highlighted the critical importance of
CTCF in the control of expression patterns in the H19/Igf2
locus. Studies at the b-globin locus had suggested that CTCF
functions by organizing the three-dimensional structure of
the locus, inducing the formation of chromatin loops that estab-
lish independent domains of transcriptional activity (15). At
the H19/Igf2 locus, recent studies have investigated diffe-
rent aspects of the interactions between the regulatory elements
(16–18). Some discrepancies have emerged from these reports.
Kurukuti et al. suggest that on the maternal chromosome, the
insulator interacts with a matrix attachment region and a differ-
entially methylated region at the Igf2 locus to generate a tight
loop around the maternal Igf2 gene, which results in silencing.
Yoon et al. report that the DMD forms direct associations
with the enhancers and the inactive Igf2 promoters. Whereas
the former studies indicate that the insulator forms a physical
impediment to activation of Igf2, the latter posits that enhancer-
blockingistheresultofdirectinteractionwiththeenhancersand
inactive promoter, generating a transcriptionally unproductive
association. The ﬁndings on the paternal-speciﬁc associations
also conﬂict. Kurukuti et al. maintain that both H19 and Igf2
are accessible to interaction with the enhancers on the paternal
chromosome, whereas Yoon et al. only tested association
between the enhancers and the active Igf2 promoter.
While each of these studies yielded insight into the organiz-
ation of the H19/Igf2 locus, the discrepancies in their results
have left some unanswered questions with respect to the mech-
anisms of enhancer-blocking and transcriptional activation. We
wished to carry out a detailed scan across the entire H19/Igf2
region to determine the parental-speciﬁc chromatin loop organ-
ization associated with the active transcriptional status as
well as repression mediated by enhancer-blocking activity or
methylation. We focused on the behavior of the endodermal
enhancers in neonatal liver, and our array of mouse models pro-
vided an opportunity to compare wild-type chromosomes with
alleles containing a variety of mutations in the CTCF sites. We
used Chromosome Conformation Capture (3C) (19) in order to
identify the long-range interactions between the promoters, the
endodermal enhancers and the DMD.
In the wild-type mouse, we ﬁnd that on the maternal chromo-
some, the enhancers make contacts throughout the region
including the H19 coding unit and promoter, up to the DMD.
On the paternal chromosome, the enhancers are engaged exclu-
sively by the Igf2 promoter and have no detectable interaction
with the H19 gene. Upon deletion of the maternal DMD, we
ﬁnd that the maternal enhancers interact in an unrestricted
way with both H19 and Igf2 regions. This suggests that the
DMD is required to conﬁne the interaction of enhancers to
the H19 region. Similarly, when the CTCF binding sites are
absent on the maternal allele, the enhancers have unlimited
access to the whole region, showing that CTCF is necessary
for enhancer-blocking activity. When the H19
DMD-9CG allele
is inherited paternally, the enhancers are mainly found at the
H19 region. Physical presence beyond the paternally estab-
lished insulator is limited, indicating that CTCF binding in
the mutant DMD restricts the access of the enhancers to the
Igf2 promoter.
RESULTS
We used 3C technology to investigate the interactions that
occur between the endodermal enhancers and the H19 and
Igf2 genes in the neonatal liver. The 3C assay employs cross-
linking, restriction digestion, ligation and PCR ampliﬁcation
of ligated fragments to determine the frequency of physical
contacts between different regions along the chromosome
(19). In our experimental approach, the samples were gener-
ated by crosses between wild-type or mutant C57BL/6J and
B6(CAST7) mice. The alleles assayed are depicted in
Figure 1. We analyzed neonatal livers, the tissue with the
highest expression of H19 and Igf2. Nuclei were treated
with formaldehyde to crosslink proteins that mediate associ-
ation between the endodermal enhancers that lie downstream
Figure 1. Representation of the Igf2/H19 loci and the mutants used in this
study, including their methylation and expression patterns. Arrows represent
expression, hatched arrows represent reduced levels of expression and ﬁlled
circles indicate DNA methylation. The H19
D3.8kb-50H19 allele has a 3.8 kb del-
etion that removes the DMD. The H19
DMD-DR allele lacks the four core
binding sites for CTCF within the DMD. The H19
DMD-9CG allele replaces
9CGs within the CTCF binding sites of the DMD.
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matin was digested with PsuI, separating fragments that con-
tained the regulatory elements of the H19/Igf2 locus. PsuI
digestion generated appropriately spaced fragments that fully
contained the regulatory elements of the H19/Igf2 locus.
There was no allelic or regional bias in the digestion pattern
(data not shown). DNA ligase was added to link the sequences
that co-localized in the nucleus, independently of their
location along the chromosome. After reversing the crosslinks
and removing the proteins, DNA sequences associated with
the endodermal enhancers were identiﬁed by PCR. In each
reaction, the PCR product was the correct size. Restriction
fragment length polymorphisms between the strains used
allowed us to distinguish the parental origin of the ligation
products. None of the products were observed in the absence
of ligation of the chromatin. At least two PCRs were carried
out for each of the two independent 3C experiments. Repre-
sentative results are shown throughout.
Allele-speciﬁc chromosome looping at the H19/Igf2 locus
In the wild-type mouse, H19 is expressed from the maternal
allele, whereas Igf2 is active on the paternal chromosome.
Our results from the 3C assay were identical for reciprocal
crosses of C57BL/6J   B6(CAST7) and indicated that the
maternal enhancers contacted the entire H19 region, including
the promoter, correlating with the active transcriptional
status of the maternal H19 gene (Fig. 2, see maternal bands
in panels 5–7). However, on the maternal chromosome, the
enhancers were not found beyond the DMD. This suggests
that the presence of an insulator assembled in this region
on the maternal copy physically bars the enhancers from
moving upstream.
Whereas the enhancers were absent from the regions
upstream of the DMD on the maternal chromosome, they
interacted freely with those regions on the paternal allele
(Fig. 2, see paternal bands in panels 1–4). This suggests that
upon inactivation of the DMD by methylation, the enhancers
are no longer restricted to the H19 region.
The paternally expressed Igf2 gene has four promoters and
exhibits differential promoter usage throughout development
(20). Restriction digestion with PsuI yields three fragments
containing Igf2 promoter sequences: fragment 10 contains
the placental promoter, fragment 13 contains promoter 1
and fragment 14 contains promoters 2 and 3 (Fig. 3A). In
the 3C assay, the paternal enhancers associated with the
three fragments containing the Igf2 promoters (Fig. 3, see
paternal bands in panels 10, 13 and 14), with the strongest
signal at promoters 2 and 3. In fact, promoter 3 is the
main origin of transcripts arising in neonatal liver. The
signal at the placental promoter is either very weak or
absent, consistent with the lack of expression from this pro-
moter in liver. These results conﬁrm that enhancer–promoter
associations are required to achieve RNA expression. Inter-
estingly, no physical proximity between the enhancers and
the H19 promoter was detected on the paternal chromosome
(Fig. 2, panels 5–7), suggesting that the enhancers are
somehow excluded from the region, possibly due to the
hypermethylation on this allele.
The DMD is required for appropriate maternal
chromosome conformation
To prove that the restricted interaction of the endodermal
enhancers on the maternal chromosome is dependent on the
presence of the insulator, we used an allele that removed the
DMD. When the H19
D3.8kb-50H19 mutation is inherited mater-
nally, the normally silent Igf2 gene is activated, resulting in
biallelic expression (14). In contrast to behavior of the wild-
type maternal chromosome, the analysis of the maternally
inherited H19
D3.8kb-50H19 allele showed contact between the
endodermal enhancers and the regions upstream of the DMD
(Fig. 4A, see maternal and paternal signals in panels 1–4).
In the absence of the DMD, the enhancers occupy Igf2 pro-
moters 1–3 on both maternal and paternal chromosomes
(Fig. 4B, see maternal and paternal bands in panels 13 and
14). These observations establish that the DMD is required
for the appropriate chromosome conformation that restricts
the maternal enhancers to the H19 promoter.
CTCF binding sites are essential in organizing the
chromosome domains
While the previous experiment showed that the DMD was
required for appropriate interactions of the locus, it remained to
be determined whether it was the CTCF binding sites within
the region that were mediating these contacts. The H19
DMD-DR
mutation lacks the four core binding sites of CTCF in the DMD
region. Mice inheriting the mutation maternally exhibit biallelic
Igf2 expression and a delay in the onset of H19 expression (12).
The 3C analysis showed that upon maternal inheritance of the
H19
DMD-DR allele, the endodermal enhancers were not conﬁned
to the H19 region, but rather displayed physical association
throughout the H19 locus (Fig. 5A, see maternal and paternal
bands in panels 1–3). This suggests that the binding of CTCF
toitscognatesitesisrequiredtoblocktheenhancersfromassoci-
ating with regions beyond the DMD.
ConsistentwiththebiallelicexpressionofIgf2,theenhancers
contact the Igf2 promoters equally on both parental chromo-
somes (Fig. 5B, see maternal and paternal bands in panels 13
and 14). This behavior is equivalent to that of the
H19
D3.8kb-50H19 allele, in which the DMD has been completely
deleted. Thus, binding of CTCF in the DMD is necessary to
abolish maternal associations between the enhancers and the
Igf2 promoters.
Methylation diminishes the strength of the insulator
function
Binding of CTCF to its recognition sites within the DMD is
methylation-sensitive. Therefore, the paternally hypermethy-
lated DMD does not exhibit enhancer-blocking activity. The
H19
DMD-9CG mutation is a parent-of-origin-speciﬁc gain-of-
function mutation, in which an insulator is assembled on the
paternal DMD (10). As a result, paternal Igf2 mRNA levels
are reduced, and the mice display a growth restriction pheno-
type. Furthermore, the normally silent paternal allele of H19 is
activated. The 3C analysis showed that the endodermal enhan-
cers interacted with the H19 promoter biallelically, consistent
with the biallelic expression of H19 in this mutant (Fig. 6A,
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observed, indicating reduced paternal interactions (Fig. 6A,
panels 1–4). Furthermore, the strength of interaction
between the enhancer and the Igf2 promoters was diminished
or undetectable (Fig. 6B, panels 13 and 14). These results indi-
cate that the ectopic insulator established on the paternal DMD
is partially successful in restricting the enhancers to the H19
region.
Figure 3. Analysis of long-range interactions between the endodermal enhancers and the Igf2 locus. (A) Schematic of the Igf2 locus, showing the exons (black
boxes) and the differentially methylated regions (hatched boxes, DMRo, DMR1, DMR2). Vertical bars indicate PsuI restriction sites, numbers beneath the sites
are the distance relative to the Igf2 exon 1 and the resulting digestion fragments from the region contacted by the endodermal enhancers are numbered (10–14).
Downstream fragments showed no contact with the endodermal enhancers (data not shown). Arrowheads represent the location of PCR primers for 3C analysis.
The white arrowhead at the endodermal enhancers downstream of H19 is the reverse primer for all reactions, which test for ligation of fragments 10–14 to the EE
fragment. An asterisk indicates a restriction polymorphism that distinguishes C57BL/6J and B6(CAST7) alleles. Samples were from wild-type progenyo f
C57BL/6J and B6(CAST7) mice (B   C, C   B), with the female indicated ﬁrst. (B) Representative gel image of 3C analysis of interactions of the endodermal
enhancers with the Igf2 locus. Shown are the 3C PCR products: D, digested with HaeIII, which distinguishes paternal (P) from maternal alleles (M), 3C, non-
digested PCR product; -L, no ligase control; þ, positive control. The endodermal enhancers on the maternal chromosome associate predominantly with frag-
ments originating in the paternal chromosome.
Figure 2. Analysis of long-range interactions at the H19 locus. (A) Schematic of the H19 locus, including the position of the coding sequence (black box), the
differentially methylated domain (hatched box, DMD) and the endodermal enhancers (circles, EE). Vertical bars indicate PsuI restriction sites, numbers beneath
the sites are the distance relative to the H19 transcriptional start site, and the resulting digestion fragments are numbered (1–9). Arrowheads represent the
location of PCR primers for 3C analysis. The white arrowhead is the reverse primer for all reactions, which test for ligation of fragments 1–9 to the EE fragment.
An asterisk indicates a restriction polymorphism that distinguishes C57BL/6J and B6(CAST7) alleles. Samples were from wild-type progeny of C57BL/6J and
B6(CAST7) mice (B   C, C   B), with the female indicated ﬁrst. (B) Representative gel image of 3C analysis at the H19 locus. Shown are the 3C PCR products:
D, digested with NlaIII, which distinguishes paternal (P) from maternal alleles (M); 3C, non-digested PCR product; -L, no ligase control; þ, positive control. The
endodermal enhancers on the maternal chromosome associate with fragments in the H19 region up to the DMD, beyond which only fragments from the paternal
chromosome are observed.
3024 Human Molecular Genetics, 2008, Vol. 17, No. 19Figure 5. The CTCF sites are necessary for the enhancer-blocking activity of the DMD. The 3C analysis was carried out on samples from a H19
DMD-DR  
B6(CAST7) cross. (A) Top, schematic of the H19
DMD-DR allele, in which the CTCF sites in the DMD have been deleted (see Fig. 2 for details). Bottom, repre-
sentative gel image of 3C PCR products: D, digested with NlaIII, which distinguishes paternal (P) from maternal (M) alleles; 3C, non-digested PCR product; -L,
no ligase control; þ, positive control. (B) Top, schematic of the Igf2 locus (see Fig. 3 for details). Bottom, representative gel image of 3C PCR products digested
with HaeIII, which distinguishes paternal (P) from maternal (M) alleles.
Figure 4. The H19 DMD is required to prevent interactions between the maternal endodermal enhancers and the Igf2 promoters. The 3C analysis was carried out
on samples from a H19
D3.8kb-50H19   B6(CAST7) cross. (A) Top, schematic of the H19
D3.8kb-50H19 allele (see Fig. 2 for details), with 3.8 kb upstream of the H19
promoter removed. Bottom, representative gel image of 3C PCR products: D, digested with NlaIII, which distinguishes paternal (P) from maternal (M) alleles;
3C, non-digested PCR product; -L, no ligase control; þ, positive control. When the H19
D3.8kb-50H19 allele is inherited maternally, the endodermal enhancers on
the maternal chromosome interact with the whole H19 region. (B) Top, schematic of the Igf2 locus (see Fig. 3 for details). Bottom, representative gel image of 3C
PCR products digested with HaeIII, which distinguishes paternal (P) from maternal (M) alleles.
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Imprinted gene expression is unique in that two disparately
regulated alleles co-exist in the same nuclear environment.
Moreover, the epigenetic status of the alleles depends on
their parental origin. The imprinted H19 /Igf2 locus has been
the focus of extensive studies. Differential DNA methylation
and allele-speciﬁc chromatin modiﬁcations have been
described in detail (13,21–23). Several targeted mutations in
the mouse have helped delimit and elucidate the function of
important cis-acting elements (5,6,10,24–26). The model
that has emerged and is strongly supported by these studies
proposes that on the maternal chromosome, a CTCF-mediated
enhancer-blocker is assembled at a region upstream of H19,
and as a result, enhancers lying downstream of H19 cannot
access the Igf2 promoters and thus activate the H19 promoter.
On the paternal chromosome, methylation inherited from the
male gamete inhibits binding of CTCF, enabling the inter-
action between the enhancers and the Igf2 gene.
The development of 3C technology has allowed us to detect
physical interactions between distant regions of the chromo-
some, supporting a model in which intervening DNA is
looped out to accommodate the functional association between
cis-acting regulatory elements (19). We have used 3C at the
H19/Igf2 locus to examine the interactions between the endo-
dermal enhancers, the H19 and Igf2 promoters, and the DMD
on each of the parental alleles. In the 3C assay, predicted inter-
actions between regulatory elements are systematically tested
by examining the relative frequency of physical proximity
between them. Although physical proximity does not necess-
arily translate into functional signiﬁcance, in conjunction with
the expression patterns and using mutations in the regulatory
elements comparatively, the association of DNA sequences
can yield insight into molecular mechanisms of transcriptional
activation and repression.
We have analyzed wild-type mice and three mouse models in
which mutations affecting the insulator activity have been tar-
geted to the DMD. Our ﬁndings are summarized in Figure 7.
We ﬁnd that in the wild-type mouse, interactions between the
endodermal enhancers and the H19 and Igf2 promoters reﬂect
the imprinted expression pattern, i.e. they occur in an allele-
speciﬁc way. On the maternal chromosome, the enhancers
contacttheactiveH19promoter,whereasonthepaternalchromo-
some, the enhancers associate with the paternally expressed Igf2
promoters.Furthermore,inallofourtargetedmousemodels,bial-
lelic expression correlates with enhancer localization at both
paternal and maternal promoters. In the paternally inherited
H19
DMD-9CG allele, CTCF is able to bind its cognate sites
within the DMD. Methylation is established normally in the
germ line, but is partially lost by the blastocyst stage, possibly
becausethepresenceofCTCFimpedesaccessofthemaintenance
DNA methyltransferase. As a result, H19 is expressed from the
normally silent paternal allele at 35% the levels of the maternal
allele in neonatal liver. Concordantly, our 3C results show the
interactions of the endodermal enhancers with both the maternal
and paternal H19 promoters. In the H19
D3.8kb-50H19 and
H19
DMD-DR mutants, both of which display biallelic Igf2
expression, the enhancers are in proximity to both maternal and
paternal Igf2 promoters. Thus, direct physical contact between
the enhancers and the promoters correlate with the gene
expression, supporting the view that the interactions are func-
tional. This is consistent with ﬁndings in a previous report (18).
Figure 6. The H19
DMD-9CG insulator is weaker than the wild-type one. The 3C analysis was carried out on samples from a B6(CAST7)   H19
DMD-9CG cross. (A)
Top, schematic of the H19
DMD-9CG allele, in which nine CpGs in the CTCF binding sites in the DMD have been replaced with alternative nucleotides (see Fig. 2
for details). Bottom, representative gel image of 3C PCR products: D, digested with NlaIII, which distinguishes paternal (P) from maternal (M) alleles; 3C,
non-digested PCR product; -L, no ligase control; þ, positive control. (B) Top, schematic of the Igf2 locus (see Fig. 3 for details). Bottom, representative gel
image of 3C PCR products digested with HaeIII, which distinguishes paternal (P) from maternal (M) alleles.
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activity of insulators does not allow physical interactions to
occur between the enhancers and regions beyond the insulator.
Speciﬁcally, in the wild-type mouse, the presence of the DMD
on the maternal chromosome restricts the association of
the endodermal enhancers to the H19 promoter and gene
body. No contacts are detected beyond the DMD. In contrast,
in the mutants in which the DMD is either removed
(H19
D3.8kb-50H19) or inactivated by deletion of the CTCF
binding sites (H19
DMD-DR), the enhancers are capable of for-
ming associations with the regions upstream of the DMD.
Indeed, on the wild-type paternal chromosome, where the insu-
lator activity is inhibited by DNA methylation, the enhancers
freely interact with the region starting immediately upstream
of the DMD. Together, these data suggest that the association
between enhancers and promoters does not occur by random
collision, but rather by a progressive scanning activity on the
part of the enhancers, which then form a stable interaction
with the ﬁrst suitable element they encounter, i.e. the H19 pro-
moteronthematernalchromosomeandtheIgf2promoteronthe
paternal chromosome (27). The fact that insulators must be
located between the enhancer and the promoter supports this
model. Strong evidence for this idea is also provided by our
H19
DMD-9CG mutation. The establishment of the insulator on
the paternal H19
DMD-9CG allele seems to act as a roadblock
for the enhancers, markedly diminishing their interactions
with chromatin lying upstream.
The presence of CTCF at the paternal DMD of the
H19
DMD-9CG allele does not completely block the interaction
of the enhancers with the upstream chromatin, although Igf2
levelsaredecreased (10).Thisindicates thattheinsulatorestab-
lished on the methylated DMD is not completely effective in
restricting the motility of the enhancers, possibly because of
the residual methylation. It also suggests that insulator activity
is not all or none, and that there could be varying degrees of
enhancer-blocking.
It is striking that in the absence of a blocking activity on the
maternal chromosome, the enhancers can both engage the H19
promoter and also advance beyond it to activate the distal Igf2
promoter, although whether contacts with both H19 and Igf2
occur simultaneously within a single cell is not known. This
suggests that, by default, the enhancers are equally capable
of activating both promoters. It also implicates that the lack
of detectable interactions at H19 on the wild-type paternal
allele is a result of presence of DNA methylation. In fact,
when the H19
DMD-DR mutation is transmitted maternally, the
H19 region is hypermethylated and contact with the enhancers
is lost. Furthermore, loss of methylation on the paternal H19
gene in the H19
DMD-9CG mutation allows the enhancers to
access the promoter, again suggesting that the determinant
for H19 silencing and the exclusion of the enhancers is
DNA methylation. Thus, our results underscore two roles for
paternal DNA methylation as a regulatory switch at this
locus. Methylation at the DMD inactivates the insulator by
inhibiting CTCF binding. In addition, methylation of the
H19 promoter might neutralize it as a target for enhancer inter-
action, promoting its bypass in favor of Igf2. These results
contrast with a previous report that detected enhancer contacts
within the H19 region paternally and concluded that the
paternal enhancers have equal access to the whole H19 and
Igf2 region (17). The discrepancy possibly arises from the
differences in choice of restriction enzyme. Our restriction
digests clearly separate the DMD, the H19 promoter and the
endodermal enhancers into distinct fragments.
The imprinting control region of the H19/Igf2 region is the
only vertebrate insulator proven to block enhancer–promoter
interactions at the endogenous locus. Two prevailing mechan-
isms of insulator action have been proposed (28–30). Topo-
logical models propose that insulators are vital for
establishing discrete structural loops that restrict the possibility
of enhancer–promoter interaction to those elements within the
domain. Interaction models assign a regulatory role to insula-
tors, proposing that they compete with the promoter for the
enhancer. Previous reports applying 3C technology to the
H19/Igf2 locus have led to different models of insulator activity.
Kurukuti et al. propose a topological model in which the insu-
lator associates with a matrix attachment region and a differen-
tially methylated region at the Igf2 locus. This would establish a
transcriptionally inert loop encompassing the Igf2 gene. Yoon
et al. favor a model in which the insulator regulates gene
activity by acting as a decoy for the enhancers and the inactive
Igf2 promoter. It is not clear in this model how the enhancers
would be available to activate H19 expression.
Our results support a model in which the enhancers track
along the chromosome and engage available promoters. The
maternal DMD poses a restriction to this scanning activity,
and as a result the enhancers are only presentat the H19 promo-
ter.WeproposethatratherthanactingasadecoyforIgf2,CTCF
binding to the DMD accomplishes this restriction by acting as a
Figure 7. Summary of the parental-speciﬁc interactions of the endodermal
enhancers along the H19/Igf2 locus in neonatal livers of wild-type and targeted
mice. Mutations are described in the legend of Figure 1 and detailed in the
text. Arrows represent expression, hatched arrows represent low levels of
expression, and ﬁlled circles indicate methylation. Stars represent regions of
contact, as detected by the 3C assay.
Human Molecular Genetics, 2008, Vol. 17, No. 19 3027transcriptional facilitator for H19. Two lines of evidence
support this idea. First, in the absence of CTCF binding sites
(H19
DMD-DR), initiation of H19 expression is delayed, clearly
implicating CTCF binding in transcriptional activity (12).
Second, the presence of CTCF binding in the paternal
H19
DMD-9CGcorrelateswithactivationofH19transcription(10).
In conclusion, we present strong evidence that at the H19/
Igf2 locus, transcriptional activity is correlated with co-local-
ization of promoters and enhancers. Our data provide new evi-
dence suggesting that the enhancer reaches the target promoter
by tracking along the intervening DNA and then looping it out.
Our analyses also indicate that the DMD blocks the enhancer
from tracking further upstream. One possibility is that the
region upstream of the DMD is not accessible to the enhancers
because the DMD is in contact with the inactive Igf2 promoter,
as suggested by Yoon et al. (18) or with the Igf2 DMR, as
reported by Murrell et al. (16). Either of these interactions
leads to the formation of a loop that would exclude the pre-
sence of the enhancers. The analyses of our mutations lend
support to a different model, in which the enhancers are
blocked because CTCF is acting as a transcriptional factor
for H19. It will be interesting to determine if there are
additional proteins involved in insulator activity, as has been
reported for cohesins (31). Furthermore, it will be exciting
to see what factors are involved in the tracking motions of
cis-acting sequences. For instance, a recent report found that
some loci can be recruited to speciﬁc nuclear positions in an
actin-dependent manner (32), and it is tempting to speculate
that actin could be involved in enhancer tracking. Ultimately,
conformational studies at the human H19/Igf2 locus will be
important to gain insight into how loss of imprinting affects
the region in disease processes.
MATERIALS AND METHODS
Chromosome conformation capture (3C)
Livers from newborn mice were homogenized and ﬁltered
through a 100 mm nylon cell strainer into 10% FBS/
DMEM. Cross-linking with 2% formaldehyde was carried
out for 10 min at room temperature and the reaction was
quenched with glycine to 0.125 M. Cells were lysed on ice
in lysis buffer (10 mM Tris pH 8.0, 10 mM NaCl, 0.2%
NP-40 and protease inhibitors). Nuclei were resuspended in
restriction buffer containing 0.3% SDS and incubated for
1 h at 378C. Triton X-100 was added to 1.8% and samples
were incubated at 378C for an additional hour. Digestion
with PsuI was carried out overnight at 378C. The reaction
was stopped by adding SDS to 2% and incubating at 658C.
An aliquot of the reaction was removed and analyzed and
compared with a digest of naked DNA to demonstrate that
the digest was complete. DNA was diluted to 2.5 ng/ml
with ligase buffer and ligation was carried out on one
half of the sample with T4 ligase at 158C for 4 h. Proteinase
K was added to and the samples incubated at 658C overnight.
DNA was puriﬁed by phenol extraction and ethanol
precipitation.
To create a pool of all possible interacting products, control
templates of deﬁned molar amounts were prepared. Control
template was prepared from a BAC encompassing the H19/
Igf2 region (RP23–50N22, CHORI). The BAC was digested
with the appropriate enzymes and ligated. Ligated fragments
of interest were ampliﬁed by PCR, gel puriﬁed and their con-
centration determined with a Nanodrop spectrophotometer.
A mix of equimolar amounts of all the fragments was prepared
and used in each reaction. The linear range of ampliﬁcation
was determined for each 3C sample. An amount of DNA
within the linear range was used for ampliﬁcation. All PCR
reactions were performed with RubyTaqTM (USB) as
follows: 678 2000,7 2 8 2000 for 15 cycles, with a decrease in
the annealing temperature of 28 every 3 cycles, followed by
25 cycles of 558 2000,7 2 8 2000 and a ﬁnal extension step of
728 103000. For all 3C assays, duplicate PCR analyses of two
independent 3C preparations were performed. Primer pairs
are described in Table 1 and their location depicted in
Figure 2. PCR products were digested with either NlaIII or
HaeIII to distinguish the C57BL/6J and B6(CAST7) alleles
and run on 12% acrylamide gels.
Table 1. Primers used in the 3C assay and the sizes (in base pairs) of the undigested and digested products for each strain
H19 primers 3C product C57BL/6J B6(CAST7)
NlaIII
1 GTCTCTGTAGGCCATCACTAAAGAGTATTA 281 136 281
2 CATTAGAAGAGAACATTTAGACTCAGACAT 251 136, 115 251
3 GTTGCTTTCTGTTTTAGTCAGTGTTCTATT 283 136, 147 234
4 CTAGTCCTCAATGTCACGTACTATTACAA 305 136, 135 170
5 GTACAATACTACATATTGCTCGGCAGAC 294 136, 158 294
6 TTTTCACAGAGTAAAAATGAAGGATCACTA 222 136 207
7 ACATAGAAAGGCAGGATAGTTAGCAAAG 350 136, 214 290
8 TATGTTTCAGTGACAAGTTAAGGTTGGACAAAG 339 136, 158 181, 158
9 GGCAGTAGACCTGACACAGCTTTTCTTC 293 128 275
EE/NlaIII GTACAGGAGGCTCTACCCCCACCCTCCGTGTG
Igf2 primers HaeIII
10 CAGTGATAACTTTAGATTGTGGATTGTAA 268 224 185
11 CCTGTTTTTATATCCTGTACCTCCTAACTA 202 158 119
12 CCTCTGCCACCAAGGCCCGAGCCGAGGCCTC 250 206 167
13 TGGCTAGAAGGCGAAAGAACGAAAAATGAAG 275 231 192
14 CTCGGATTCCAGAAAATGGA 417 201, 216 193
EE/Hae III AAAAGGGACTTCAGACCTTATGCCCCCCACCTACCAG
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